Protalix BioTherapeutics, Inc. (PLX)
NYSE American · Manufacturing · Biological products, (no diagnostic substances)
$2.72−$0.0300 (−1.09%) on the dayAs of the close; data may be delayed.
PLX price, last 12 months
Key stats
- Previous close
- $2.75
- Open
- $2.75
- Day range
- $2.70 – $2.80
- 52-week range
- $1.60 – $3.19
- Volume
- 351.2K
- Avg volume (20 days)
- 698.9K
- Market cap
- $219.2M
Performance
1W+1.1%
1M+9.7%
3M+18.3%
6M+28.9%
YTD+51.1%
1Y+32.0%
vs S&P 500, 1Y+15.3 pts
Technicals and fundamentals
About Protalix BioTherapeutics, Inc.
Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.
- Sector
- Manufacturing
- Industry
- Biological products, (no diagnostic substances)
- Listed on
- NYSE American
- Market cap
- $219.2M